Results 21 to 30 of about 12,425 (210)

Pericardiocentesis: ultrasound guidance is essential

The Ultrasound Journal, 2022
Background Pericardial effusion is a common entity which may have important implications in patient’s prognosis. In several cases, pericardiocentesis is indicated for diagnostic and/or therapeutic purposes.
Pablo Blanco, Liliana Figueroa, María Fernanda Menéndez, Belén Berrueta   +3 more
doaj   +1 more source

Autoimmune Haemolytic Anaemia, Acute Pericarditis with Cardiac Tamponade as Presenting Manifestations in Systemic Lupus Erythematosus- A Rare Case Report [PDF]

Journal of Clinical and Diagnostic Research, 2023
Systemic Lupus Erythematosus (SLE) is an autoimmune disorder that affects mostly young women in which tissue-binding autoantibodies and immune complexes cause damage to organs and tissues.
Apurva Dubey, Sourya Acharya, Samarth Shukla, Sunil Kumar, Himanshu Dodeja   +4 more
doaj   +1 more source

Prognostic Factors and Overall Survival After Pericardiocentesis in Patients With Cancer and Thrombocytopenia

Frontiers in Cardiovascular Medicine, 2021
Background: Pericardiocentesis is an important diagnostic and therapeutic tool for cancer-associated pericardial effusion. Limited safety and outcomes data exists regarding the management of malignancy-related pericardial effusion in patients with ...
Nathaniel R. Wilson, Michelle T. Lee, Clarence D. Gill, Astrid Serauto Canache, Teodora Donisan, Dinu V. Balanescu, Juhee Song, Nicolas Palaskas, Juan Lopez-Mattei, Mehmet Cilingiroglu, Konstantinos Marmagkiolis, Cezar A. Iliescu, Cezar A. Iliescu   +12 more
doaj   +1 more source

Pericardiocentesis decompression syndrome: An uncommon complication of a common procedure

IHJ Cardiovascular Case Reports, 2019
We report a case of reversible left ventricular regional dysfunction after pericardiocentesis performed for imminent cardiac tamponade. This complication termed pericardiocentesis decompression syndrome is often unrecognised and underreported.
Ankit Mahajan, Nipun Mahajan, Ashwani Suri, Kunal Mahajan   +3 more
doaj   +1 more source

Effect of prednisolone on inflammatory markers in pericardial tuberculosis: A pilot study [PDF]

, 2017
Background: Pericardial disorders are a common cause of heart disease, and the most common cause of pericarditis in developing countries is tuberculous (TB) pericarditis.
Lai, RP, Mayosi, BM, Ntsekhe, M, Ross, IL, Shenje, J, Wilkinson, KA, Wilkinson, RJ   +6 more
core   +1 more source

Tuberculous Pericarditis [PDF]

, 2018
info:eu-repo/semantics ...
Faria, D, Freitas, A
core   +1 more source

Massive pericardial effusion caused by hypothyroidism. [PDF]

, 2018
Although mild pericardial effusion is a usual finding in patients with hypothyroidism, massive pericardial effusion or pericardial tamponade is rare and customarily related to severe hypothyroidism. The diagnosis of hypothyroidism should be considered in
Germano, A, Roque, D, Schmitt, W
core   +1 more source

Differences in outcomes between surgical pericardial window and pericardiocentesis in children with postpericardiotomy syndrome

Annals of Pediatric Cardiology, 2023
Children with postpericardiotomy syndrome may develop hemodynamically significant pericardial effusions warranting drainage by surgical pericardial window or pericardiocentesis. The optimal approach is unknown.
Joshua T. Fields, Conor P. O’Halloran, Paul Tannous, Brock A. Karolcik, Scott M. Bradley, Minoo N. Kavarana, John F. Rhodes, Eric M. Graham, John M. Costello   +8 more
doaj   +1 more source

Emergency Veno-Arterial Extracorporeal Membrane Oxygenation for Pericardial Decompression Syndrome

Case Reports in Cardiology, 2022
Background. Pericardiocentesis is a therapeutic lifesaving intervention for patients presenting with cardiogenic shock due to pericardial effusion with signs of tamponade.
Mohamed Laimoud, Patricia Machado, Andrea Rossi Zadra, Mary Maghirang, Ali Alenazy   +4 more
doaj   +1 more source

Hemopericardium and Cardiac Tamponade Associated with Dabigatran Use [PDF]

, 2012
OBJECTIVE: To describe 2 cases of hemopericardium following treatment with dabigatran. CASE SUMMARIES: A 70-year-old male with a history of dabigatran use presented with cough, fatigue, and bloody stools.
Dy, Eliza A., Shiltz, Dane L.
core   +2 more sources